tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market
TVTX
Travere Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Travere Therapeutics (TVTX) Stock News & Sentiment

Compare
502 Followers
Buy Rating for Travere Therapeutics: Strong Market Position and Growth Potential with Filspari and FSGS Expansion
Premium
Ratings
Buy Rating for Travere Therapeutics: Strong Market Position and Growth Potential with Filspari and FSGS Expansion
24d ago
TVTX
Buy Rating on Travere Therapeutics: Undervaluation Amidst IgAN and FSGS Opportunities
Premium
Ratings
Buy Rating on Travere Therapeutics: Undervaluation Amidst IgAN and FSGS Opportunities
1M ago
TVTX
Buy Rating for Travere Therapeutics: Anticipated FDA Approval and Strategic Developments Signal Significant Upside Potential
Premium
Ratings
Buy Rating for Travere Therapeutics: Anticipated FDA Approval and Strategic Developments Signal Significant Upside Potential
1M ago
TVTX
Buy Rating for Travere Therapeutics Amid Filspari’s FDA Review and Market Potential
Premium
Ratings
Buy Rating for Travere Therapeutics Amid Filspari’s FDA Review and Market Potential
2M ago
TVTX
Travere Therapeutics Holds Annual Meeting, Elects Directors
Premium
Company Announcements
Travere Therapeutics Holds Annual Meeting, Elects Directors
2M ago
8K
TVTX
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
Premium
Ratings
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
2M ago
TVTX
Buy Rating Reaffirmed for Travere Therapeutics Amid FDA Review and Market Overreaction
Premium
Ratings
Buy Rating Reaffirmed for Travere Therapeutics Amid FDA Review and Market Overreaction
2M ago
TVTX
More TVTX News >

TVTX News on the Web

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX)
TipRanks News
Neutral
Citi trims Travere target, opens 'upside 90-day catalyst watch'
The Fly
Neutral
Cito trims Travere target, opens 'upside 90-day catalyst watch'
The Fly
Neutral
Stifel Nicolaus Remains a Hold on Travere Therapeutics (TVTX)
TipRanks News
Neutral
Travere Therapeutics selloff should be bought, says Citi
The Fly
Neutral
Why Travere Therapeutics, Inc.’s (TVTX) Stock Is Down 18.46%
AAII
Neutral
Travere Therapeutics’ FDA Acceptance for FILSPARI Application
TipRanks News
Neutral
Why Travere Therapeutics, Inc.’s (TVTX) Stock Is Up 5.29%
AAII
Neutral

News Score - Last 7 Days

Neutral
TVTX
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TVTX’s Media Buzz Sentiment?
Currently, no data Available
What is TVTX’s weekly average amount of articles?
Currently, no data Available
What is TVTX’s News Sentiment?
50% of articles about TVTX were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    NEVIPascal Biosciences Inc
    JNJJohnson & Johnson
    HRMYHarmony Biosciences Holdings
    WATWaters
    ABTAbbott Laboratories
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing